A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse modelsPär Larsson, Malin Flodström‐Tullberg, Renata Utorova et al.|Diabetologia|2014Cited by 43